AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22952365 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed porcine intestinal mucosa (PEP50)
Number of subjects: 92
Study 22952365 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed porcine intestinal mucosa (PEP2+)
Number of subjects: 92
Study 22952365 — intervention group
Group type: COMPARATOR
Intervention: Fish meal
Number of subjects: 92
Study 21242774 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigator intervention
Number of subjects: 78
Study 19695189 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ganciclovir (7.5 mg/kg in inducement phase, 10 mg/kg in maintaining phase)
Number of subjects: 167
Study 19695189 — intervention group
Group type: COMPARATOR
Intervention: Low-dose ganciclovir (5 mg/kg in inducement and maintaining phases)
Number of subjects: 167
Study 17091363 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms measured within 4 weeks after treatment
Number of subjects: 105
Study 17091363 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment type (radical prostatectomy, external beam radiation, or brachytherapy)
Number of subjects: 105
Study 14727275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mL/kg of bupivacaine 0.25% with ketamine 0.25 mg/kg
Number of subjects: 60
Study 14727275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mL/kg of bupivacaine 0.25% with ketamine 0.5 mg/kg
Number of subjects: 60
Study 14727275 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mL/kg of bupivacaine 0.25% with ketamine 1 mg/kg
Number of subjects: 60
Study 14727275 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (bupivacaine 0.25% with ketamine 0.25 mg/kg)
Number of subjects: 60
Study 11349178 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogen (0.625 mg) and medroxyprogesterone acetate (5 mg)
Number of subjects: 208
Study 11349178 — intervention group
Group type: COMPARATOR
Intervention: 17beta-estradiol (2 mg) and norethindrone acetate (1 mg)
Number of subjects: 208
Study 9139489 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined injection of acellular pertussis-diphtheria-tetanus vaccine with Haemophilus influenzae b conjugate vaccine
Number of subjects: 468
Study 8375540 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylamide gel (1.5%, 1.6%, 1.7%, 1.8%)
Number of subjects: 169
Study 8375540 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylamide gel (1.8%)
Number of subjects: 169
Study 8375540 — intervention group
Group type: COMPARATOR
Intervention: Human cervical mucus (CM)
Number of subjects: 169
Study 8375540 — intervention group
Group type: COMPARATOR
Intervention: Standard sperm analyses
Number of subjects: 169
Study 8375540 — intervention group
Group type: COMPARATOR
Intervention: Postcoital testing
Number of subjects: 169
Study 3526819 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 10
Study 29389037 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 593
Study 29389037 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 593
Study 26684594 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair (TEVAR)
Number of subjects: 0
Study 26684594 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (anti-impulse therapy)
Number of subjects: 0
Study 25024190 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-level grouping based on relative position of objects
Number of subjects: 0
Study 25024190 — intervention group
Group type: COMPARATOR
Intervention: Control studies for low-level grouping
Number of subjects: 0
Study 22924949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 2 mg twice daily
Number of subjects: 197
Study 22924949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 197
Study 22924949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 15 mg twice daily
Number of subjects: 197
Study 22924949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 22924949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (all doses)
Number of subjects: 197
Study 20668250 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley protein
Number of subjects: 23
Study 20668250 — intervention group
Group type: COMPARATOR
Intervention: Calcium caseinate
Number of subjects: 23
Study 18590518 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised cognitive behavioural therapy (CBT)
Number of subjects: 300
Study 18590518 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual by a GP
Number of subjects: 300
Study 18590518 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised cognitive behavioural therapy in combination with usual GP care
Number of subjects: 300
Study 16092109 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term antiparkinson therapy
Number of subjects: 21
Study 16092109 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study 16092109 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients before therapy
Number of subjects: 21
Study 16092109 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with motor improvement
Number of subjects: 21
Study 12042268 — intervention group
Group type: EXPERIMENTAL
Intervention: Double lumen catheter (CC)
Number of subjects: 650
Study 12042268 — intervention group
Group type: COMPARATOR
Intervention: Single lumen catheter (TCC)
Number of subjects: 650
Study 10598602 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 30 min
Number of subjects: 75
Study 10598602 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 45 min
Number of subjects: 75
Study 10598602 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 15 min
Number of subjects: 75
Study 10598602 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation for 0 min (sham treatment)
Number of subjects: 75
Study 10598602 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 30 min and 45 min
Number of subjects: 75
Study 10598602 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation for 15 to 45 min
Number of subjects: 75
Study 7489529 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program (54.3 ± 7.7 mins/day, 4.9 ± 1.7 days/week, 54% maximum heart rate reserve, for six months)
Number of subjects: 25
Study 7489529 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program
Number of subjects: 25
Study 7489529 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study 1538102 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected wrist position (35 degrees of extension and 7 degrees of ulnar deviation)
Number of subjects: 20
Study 1538102 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist deviated into flexion, extension, or radial/ulnar deviation of 10 to 15 degrees
Number of subjects: 20
Study 1538102 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected position with a minimum of 25 degrees of wrist extension
Number of subjects: 20
Study 1538102 — intervention group
Group type: EXPERIMENTAL
Intervention: Grasp size using Jamar dynamometer
Number of subjects: 20
Study 6087753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim
Number of subjects: 0
Study 6087753 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 0
Study 6087753 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sulfamethoxazole and trimethoprim and ketoconazole
Number of subjects: 0
Study 6087753 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 31195244 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 285
Study 31195244 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 285
Study 31195244 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 285
Study 31195244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study 31195244 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison (BD vs NPC)
Number of subjects: 285
Study 30449275 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluralaner plus moxidectin (Bravecto® Plus) - minimum dose rates 40 mg/kg and 2 mg/kg, respectively
Number of subjects: 273
Study 30449275 — intervention group
Group type: COMPARATOR
Intervention: Emodepside plus praziquantel (Profender®) - minimum dose rates 3 mg/kg and 12 mg/kg, respectively
Number of subjects: 273
Study 27320173 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin plus extended release niacin (ERN), 1500 to 2000 mg/day
Number of subjects: 3094
Study 27320173 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin plus placebo
Number of subjects: 3094
Study 24571700 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride (SnF2) dentifrice (1,100 ppm F)
Number of subjects: 3
Study 24571700 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) dentifrice (1,100 ppm F)
Number of subjects: 3
Study 24571700 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium monofluorophosphate (SMFP) dentifrice (1,000 ppm F)
Number of subjects: 3
Study 24571700 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride (AmF) dentifrice (1,400 ppm F)
Number of subjects: 3
Study 22898678 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg per day
Number of subjects: 145
Study 22898678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 20693876 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous ketamine on induction of anesthesia and continuous infusion at 10 microg kg(‐1) min(‐1) until wound closure
Number of subjects: 102
Study 20693876 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg intravenous ketamine
Number of subjects: 102
Study 20693876 — intervention group
Group type: COMPARATOR
Intervention: Saline of equivalent volume (placebo)
Number of subjects: 102
Study 18931624 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based HIV mobile voluntary counseling and testing
Number of subjects: 48
Study 18931624 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based standard voluntary counseling and testing (VCT)
Number of subjects: 48
Study 18931624 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence to intervention components
Number of subjects: 48
Study 18931624 — intervention group
Group type: EXPERIMENTAL
Intervention: Study outcomes including prevalence of recent HIV infection and community-level HIV stigma
Number of subjects: 48
Study 16401958 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 51
Study 16401958 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 51
Study 12876177 — intervention group
Group type: EXPERIMENTAL
Intervention: Human synthetic secretin (HSS) 2 CU/kg
Number of subjects: 62
Study 12876177 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 62
Study 10561942 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 per cent isotretinoin gel (Isotrex)
Number of subjects: 30
Study 10561942 — intervention group
Group type: COMPARATOR
Intervention: Vehicle base with broad spectrum sunscreen (SPF 28)
Number of subjects: 30
Study 8712430 — intervention group
Group type: EXPERIMENTAL
Intervention: Before group (22 patients, 11 failed blocks)
Number of subjects: 46
Study 8712430 — intervention group
Group type: EXPERIMENTAL
Intervention: After group (12 patients)
Number of subjects: 46
Study 8712430 — intervention group
Group type: COMPARATOR
Intervention: None group (12 patients)
Number of subjects: 46
Study 2070703 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (100 mg nocte)
Number of subjects: 124
Study 2070703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg twice daily)
Number of subjects: 124
Study 2070703 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (800 mg nocte)
Number of subjects: 124
Study 2070703 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (40 mg nocte)
Number of subjects: 124
Study 6680214 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical sodium fluoride gel
Number of subjects: 220
Study 6680214 — intervention group
Group type: COMPARATOR
Intervention: High content fluoride toothpaste (1350 ppm F‐)
Number of subjects: 220
Study 30936138 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' identification of low cardiac output syndrome based on survey responses at 5 time points (0, 6, 12, 18, and 24 hours postoperatively).
Number of subjects: 10
Study 30936138 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of agreement by years of experience of nurses.
Number of subjects: 10
Study 28454522 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation training
Number of subjects: 60
Study 28454522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based training
Number of subjects: 60
Study 28454522 — intervention group
Group type: COMPARATOR
Intervention: Control group (depression only)
Number of subjects: 60
Study 28454522 — intervention group
Group type: COMPARATOR
Intervention: Control group (alcohol use disorder only)
Number of subjects: 60
Study 28454522 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 60
Study 25548261 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (CETP rs3764261 CC genotype)
Number of subjects: 903
Study 25548261 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (CETP rs3764261 CC genotype)
Number of subjects: 903
Study 25548261 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (other genotypes)
Number of subjects: 903
Study 25548261 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (other genotypes)
Number of subjects: 903
Study 25548261 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat weight-loss diet (CETP rs3764261 CC genotype)
Number of subjects: 903
Study 24388320 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide therapy
Number of subjects: 512
Study 24388320 — intervention group
Group type: COMPARATOR
Intervention: ICU readmission
Number of subjects: 512
Study 24388320 — intervention group
Group type: COMPARATOR
Intervention: Health care costs
Number of subjects: 512
Study 22414819 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/d)
Number of subjects: 826
Study 22414819 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/d) after vitamin A supplementation (200,000 IU)
Number of subjects: 826
Study 22414819 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 826
Study 22414819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 826
Study 20014458 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN plus ribavirin (PR)
Number of subjects: 45
Study 20014458 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN plus ketoprofen
Number of subjects: 45
Study 20014458 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN plus ribavirin and ketoprofen
Number of subjects: 45
Study 17595779 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 or more courses of intravenous topotecan
Number of subjects: 523
Study 17595779 — intervention group
Group type: COMPARATOR
Intervention: 6 or fewer courses of intravenous topotecan
Number of subjects: 523
Study 17595779 — intervention group
Group type: EXPERIMENTAL
Intervention: topotecan treatment
Number of subjects: 523
Study 15250785 — intervention group
Group type: EXPERIMENTAL
Intervention: Context noise and item noise
Number of subjects: 0
Study 15250785 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental data fitting with retrieving effectively from memory model
Number of subjects: 0
Study 11991908 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard surgery (transurethral resection of the prostate)
Number of subjects: 340
Study 11991908 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy (non-contact laser therapy)
Number of subjects: 340
Study 11991908 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (no active intervention)
Number of subjects: 340
Study 9865685 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (Taxotere)
Number of subjects: 0
Study 9865685 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C and vinblastine
Number of subjects: 0
Study 9865685 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 0
Study 9865685 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 0
Study 7630998 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance for Health intervention (aerobic dance program, health education curriculum twice a week, dance-oriented physical education class three times a week)
Number of subjects: 110
Study 7630998 — intervention group
Group type: COMPARATOR
Intervention: Usual physical activity (mostly playground activities)
Number of subjects: 110
Study 7455835 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency (including iron deficiency anaemia)
Number of subjects: 15
Study 7455835 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency anaemia
Number of subjects: 15
Study 7455835 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study 30690869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-Use Supplementary Food (RUSF) as a snack
Number of subjects: 95
Study 30690869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-Use Supplementary Food (RUSF) mixed with borbor (white rice porridge)
Number of subjects: 95
Study 30690869 — intervention group
Group type: COMPARATOR
Intervention: Corn-soy blend plus plus (CSB++)
Number of subjects: 95
Study 30690869 — intervention group
Group type: COMPARATOR
Intervention: Borbor fortified with micronutrient powder (MNP)
Number of subjects: 95
Study 30690869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-Use Supplementary Food (RUSF) snack
Number of subjects: 95
Study 28141620 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 8°C for 10 min
Number of subjects: 10
Study 28141620 — intervention group
Group type: COMPARATOR
Intervention: Whole body cryotherapy (WBC) at -110°C for 2 min
Number of subjects: 10
Study 28141620 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CWI and WBC
Number of subjects: 10
Study 26107810 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 12
Study 26107810 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 12
Study 26107810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 24401143 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) for 16 sessions (45 min each)
Number of subjects: 9
Study 24401143 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training for 16 sessions (45 min each)
Number of subjects: 9
Study 24401143 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (RAGT and strength training)
Number of subjects: 9
Study 22452620 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (35 kcal/Kg/day for 4 weeks followed by oral nutritional support for 2 months)
Number of subjects: 99
Study 22452620 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic support (control group)
Number of subjects: 99
Study 22452620 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 99
Study 19167189 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined transbuccal and intra-oral approach
Number of subjects: 140
Study 19167189 — intervention group
Group type: COMPARATOR
Intervention: Intra-oral alone
Number of subjects: 140
Study 17678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medications
Number of subjects: 0
Study 17678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 0
Study 17678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 17678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive behavior modification
Number of subjects: 0
Study 17678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 15364688 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 U of botulinum toxin type A
Number of subjects: 13
Study 15364688 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 U of botulinum toxin type A
Number of subjects: 13
Study 15364688 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 U of botulinum toxin type A
Number of subjects: 13
Study 15364688 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of botulinum toxin type A
Number of subjects: 13
Study 12324288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling with an extra 350 micro g folate derived from food/d
Number of subjects: 0
Study 12324288 — intervention group
Group type: COMPARATOR
Intervention: Unfortified breakfast cereal (control group)
Number of subjects: 0
Study 11475744 — intervention group
Group type: EXPERIMENTAL
Intervention: Chanlibao (CLB)
Number of subjects: 80
Study 11475744 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OTC)
Number of subjects: 80
Study 11475744 — intervention group
Group type: COMPARATOR
Intervention: Control group (natural labor)
Number of subjects: 80
Study 7857345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg sachets after fasting
Number of subjects: 12
Study 7857345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg sachets after a standard meal
Number of subjects: 12
Study 7857345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg ampoules after fasting
Number of subjects: 12
Study 7857345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg ampoules after a standard meal
Number of subjects: 12
Study 7857345 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both formulations (sachets and ampoules)
Number of subjects: 12
Study 2632449 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic aspirin
Number of subjects: 0
Study 2632449 — intervention group
Group type: COMPARATOR
Intervention: Systemic vitamin E
Number of subjects: 0
Study 662249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin alone
Number of subjects: 0